MELISSA CORDOVA: Open Payments
NPI 1124507751 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 61 payments from 13 companies in 2025. Trend: 2023 $584 · 2024 $1,182 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $302 |
| Madrigal Pharmaceuticals | 7 | $264 |
| Janssen Biotech, Inc. | 8 | $151 |
| Ardelyx, Inc. | 5 | $119 |
| PFIZER INC. | 6 | $114 |
| GENZYME CORPORATION | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Novo Nordisk Inc | 2 | $34 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, IBSRELA, VELSIPITY, CREON, MAVYRET, LINZESS.
Industry payments across FL — which companies pay providers there.
